Clinical Trial Update: Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction [Phase 3]

View source ↗

Summary

Phase 3 trial update for low-molecular-weight heparin in fetal growth restrictions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Retardation

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Fetal Growth Retardation | Phase 3 | Status: COMPLETED